Targeting Transcription Factor-BAF Interactions in Cancer

Time: 10:00 am
day: Day Two


  • Understanding how transcription factors make for compelling drug targets, but have been historically hard-to-drug
  • Spotlighting transcription factors involvement with the BAF chromatin remodeling complex to open chromatin
  • Developing a drug discovery platform to inhibit TF-BAF interactions; the Foghorn approach